Medidata Solutions (NASDAQ:MDSO) had its target price cut by Morgan Stanley from $86.00 to $79.00 in a research note released on Friday morning. They currently have an overweight rating on the stock.

A number of other equities analysts also recently weighed in on MDSO. Royal Bank of Canada set a $82.00 price target on Medidata Solutions and gave the stock a hold rating in a research report on Thursday. BidaskClub upgraded Medidata Solutions from a sell rating to a hold rating in a report on Tuesday, January 16th. Dougherty & Co started coverage on Medidata Solutions in a report on Thursday, November 2nd. They set a neutral rating for the company. Deutsche Bank started coverage on Medidata Solutions in a report on Friday, December 8th. They set a buy rating and a $78.00 price objective for the company. Finally, Zacks Investment Research cut Medidata Solutions from a hold rating to a sell rating in a report on Thursday, November 2nd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company. Medidata Solutions has an average rating of Buy and a consensus target price of $83.00.

Shares of Medidata Solutions (MDSO) traded up $2.36 during midday trading on Friday, reaching $64.97. The company’s stock had a trading volume of 1,590,768 shares, compared to its average volume of 643,297. The firm has a market capitalization of $3,660.24, a P/E ratio of 87.80, a PEG ratio of 3.24 and a beta of 1.58. The company has a current ratio of 1.50, a quick ratio of 3.37 and a debt-to-equity ratio of 0.20. Medidata Solutions has a 1 year low of $54.36 and a 1 year high of $85.92.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Thursday, February 8th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.10. The firm had revenue of $141.20 million for the quarter, compared to the consensus estimate of $140.65 million. Medidata Solutions had a return on equity of 11.59% and a net margin of 8.14%. The business’s revenue was up 13.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.33 earnings per share. equities analysts forecast that Medidata Solutions will post 0.93 EPS for the current fiscal year.

In other Medidata Solutions news, COO Michael L. Capone sold 5,000 shares of the stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $66.33, for a total transaction of $331,650.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Rouven Bergmann sold 3,000 shares of the stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $70.00, for a total value of $210,000.00. Following the sale, the chief financial officer now owns 84,775 shares of the company’s stock, valued at $5,934,250. The disclosure for this sale can be found here. Insiders have sold 29,010 shares of company stock valued at $1,962,206 over the last 90 days. Corporate insiders own 5.80% of the company’s stock.

A number of institutional investors have recently modified their holdings of MDSO. Canada Pension Plan Investment Board grew its holdings in Medidata Solutions by 2,994.6% during the 3rd quarter. Canada Pension Plan Investment Board now owns 1,151,200 shares of the company’s stock worth $89,863,000 after acquiring an additional 1,114,000 shares during the period. American Century Companies Inc. grew its holdings in Medidata Solutions by 610.9% during the 3rd quarter. American Century Companies Inc. now owns 1,186,843 shares of the company’s stock worth $92,645,000 after acquiring an additional 1,019,883 shares during the period. Eagle Asset Management Inc. grew its holdings in Medidata Solutions by 292.9% during the 3rd quarter. Eagle Asset Management Inc. now owns 835,286 shares of the company’s stock worth $66,371,000 after acquiring an additional 622,694 shares during the period. State Street Corp grew its holdings in Medidata Solutions by 27.7% during the 2nd quarter. State Street Corp now owns 1,828,913 shares of the company’s stock worth $143,022,000 after acquiring an additional 396,793 shares during the period. Finally, Global Thematic Partners LLC grew its holdings in Medidata Solutions by 37.3% during the 4th quarter. Global Thematic Partners LLC now owns 1,429,138 shares of the company’s stock worth $90,564,000 after acquiring an additional 388,608 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Medidata Solutions (MDSO) Price Target Cut to $79.00 by Analysts at Morgan Stanley” was reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.watchlistnews.com/medidata-solutions-mdso-price-target-cut-to-79-00-by-analysts-at-morgan-stanley/1857578.html.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.